A new drug to treat advanced skin cancer, or metastatic melanoma, has been shown to nearly double average survival time in a study of more than 130 patients, researchers said Wednesday.
Related posts:
Mom's nicotine gum, patches tied to colic in babies: study
Uganda opposition leader injured as police disperse
Foods' Aromas Might Help You Lose Weight
California voters narrowly reject new tobacco tax
TB patient charged in Calif for not taking meds
Old drug for arthritis is effective against killer parasites
Views: 0